I wonder if the $20m acquisition facility will be aimed at Adherium (I hold.) With Respiri now in RPM and solely focused on the US, and if the terms were realistic, a deal could make a lot more sense to ADR shareholders than it did a few years ago.
Also, a well funded merged group would be far more likely to get traction on the ASX than either company could on its own.
Ann: $6.5m raised for US expansion, $20m commitment secured, page-5
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $51.39M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.3¢ | 3.7¢ | $301.9K | 7.521M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 369145 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 131324 | 1 |
View Market Depth
| Last trade - 15.45pm 04/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |